RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma ; volume:12 ; number:6 ; year:2020 ; extent:17
EMBO molecular medicine / European Molecular Biology Organization ; 12, Heft 6 (2020) (gesamt 17)

Urheber
Smith, Henry G.
Jamal, Kunzah
Dayal, Jasbani HS
Tenev, Tencho
Kyula‐Currie, Joan
Guppy, Naomi
Gazinska, Patrycja
Roulstone, Victoria
Liccardi, Gianmaria
Davies, Emma
Roxanis, Ioannis
Melcher, Alan A.
Hayes, Andrew J.
Inman, Gareth J.
Harrington, Kevin J.
Meier, Pascal

DOI
10.15252/emmm.201910979
URN
urn:nbn:de:101:1-2022062706562075849392
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:38 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Smith, Henry G.
  • Jamal, Kunzah
  • Dayal, Jasbani HS
  • Tenev, Tencho
  • Kyula‐Currie, Joan
  • Guppy, Naomi
  • Gazinska, Patrycja
  • Roulstone, Victoria
  • Liccardi, Gianmaria
  • Davies, Emma
  • Roxanis, Ioannis
  • Melcher, Alan A.
  • Hayes, Andrew J.
  • Inman, Gareth J.
  • Harrington, Kevin J.
  • Meier, Pascal

Ähnliche Objekte (12)

Perioperative treatment of soft-tissue sarcoma

Perioperative treatment of soft-tissue sarcoma

Intraoperative radiation therapy (IORT) in soft-tissue sarcoma

Intraoperative radiation therapy (IORT) in soft-tissue sarcoma

Worse Survival in Elderly Patients with Extremity Soft-Tissue Sarcoma

Worse Survival in Elderly Patients with Extremity Soft-Tissue Sarcoma

SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

Relationship of angiogenic and apoptotic activities in soft-tissue sarcoma

Relationship of angiogenic and apoptotic activities in soft-tissue sarcoma

Configuration of soft-tissue sarcoma on MRI correlates with grade of malignancy

Configuration of soft-tissue sarcoma on MRI correlates with grade of malignancy

Customized CRISPR/Cas9 screens to identify novel targets for soft-tissue sarcoma therapy

Hochschulschrift

Customized CRISPR/Cas9 screens to identify novel targets for soft-tissue sarcoma therapy

Lower limb function and quality of life after ILP for soft-tissue sarcoma

Lower limb function and quality of life after ILP for soft-tissue sarcoma

Advances in soft-tissue sarcoma – There are no mistakes, only lessons to learn!

Advances in soft-tissue sarcoma – There are no mistakes, only lessons to learn!

MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines

MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines

Evaluating [225Ac]Ac-FAPI-46 for the treatment of soft-tissue sarcoma in mice

Evaluating [225Ac]Ac-FAPI-46 for the treatment of soft-tissue sarcoma in mice

Verbundene Objekte